PHIBRO ANIMAL HEALTH CORP
PAHC · XNASCIK 1069899fmd_1369R9FGB7EQYE7SJ0QXRQ21RPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2011 to Sep 30, 2026, 58 periods
Latest annual · FY2026
Millions- Total revenues
- 1,518
- Gross profit
- 513
- Operating income
- 194
- Net income
- 100
- Free cash flow
- 10
Latest quarter · Q1 FY2027
Millions- Total revenues
- 387
- Gross profit
- 129
- Operating income
- 50
- Net income
- 30
- Free cash flow
- 7
Daily close · PAHCIEX trades only
Nov 13, 2025 to Nov 11, 2026 · 250 sessions35.16 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2023 to FY2026
- +15.8%
- Revenue, 5 yearsFY2021 to FY2026
- +12.7%
- Net income, 5 yearsFY2021 to FY2026
- +12.9%
PHIBRO ANIMAL HEALTH CORP (PAHC) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.5 billion | $1.3 billion | +17.1% | 10-K 2026-08-26 · proof |
| Gross profit | $512.5 million | $399.9 million | +28.1% | 10-K 2026-08-26 · proof |
| Operating income | $194.4 million | $110.5 million | +76% | 10-K 2026-08-26 · proof |
| Net income | $99.7 million | $48.3 million | +106.6% | 10-K 2026-08-26 · proof |
| Cash from operating activities | $69 million | $80.1 million | -13.9% | 10-K 2026-08-26 · proof |
| Free cash flow | $9.9 million | $41.8 million | -76.4% | 10-K 2026-08-26 · proof |
| Total assets | $1.5 billion | $1.4 billion | +10.3% | 10-K 2026-08-26 · proof |
| Total liabilities | $1.1 billion | $1.1 billion | +3.8% | 10-K 2026-08-26 · proof |
| Cash and cash equivalents | $61.4 million | $68 million | -9.7% | 10-K 2026-08-26 · proof |
| Total debt | $616.8 million | $631.7 million | -2.4% | 10-Q 2026-11-04 · proof |
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s revenue in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported revenue of $1.5 billion for fiscal 2026 (the year ended Jun 30, 2026), against $1.3 billion the year before (+17.1%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s gross profit in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported gross profit of $512.5 million for fiscal 2026 (the year ended Jun 30, 2026), against $399.9 million the year before (+28.1%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s operating income in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported operating income of $194.4 million for fiscal 2026 (the year ended Jun 30, 2026), against $110.5 million the year before (+76%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s net income in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported net income of $99.7 million for fiscal 2026 (the year ended Jun 30, 2026), against $48.3 million the year before (+106.6%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s cash from operating activities in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported cash from operating activities of $69 million for fiscal 2026 (the year ended Jun 30, 2026), against $80.1 million the year before (-13.9%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What was PHIBRO ANIMAL HEALTH CORP (PAHC)'s free cash flow in fiscal 2026?
- PHIBRO ANIMAL HEALTH CORP (PAHC) reported free cash flow of $9.9 million for fiscal 2026 (the year ended Jun 30, 2026), against $41.8 million the year before (-76.4%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What are PHIBRO ANIMAL HEALTH CORP (PAHC)'s total assets?
- As of Jun 30, 2026, PHIBRO ANIMAL HEALTH CORP (PAHC) reported total assets of $1.5 billion, against $1.4 billion a year earlier (+10.3%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What are PHIBRO ANIMAL HEALTH CORP (PAHC)'s total liabilities?
- As of Jun 30, 2026, PHIBRO ANIMAL HEALTH CORP (PAHC) reported total liabilities of $1.1 billion, against $1.1 billion a year earlier (+3.8%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What are PHIBRO ANIMAL HEALTH CORP (PAHC)'s cash and cash equivalents?
- As of Jun 30, 2026, PHIBRO ANIMAL HEALTH CORP (PAHC) reported cash and cash equivalents of $61.4 million, against $68 million a year earlier (-9.7%). Source: the 10-K filed with the SEC on Aug 26, 2026. SEC
- What is PHIBRO ANIMAL HEALTH CORP (PAHC)'s total debt?
- As of Jun 30, 2026, PHIBRO ANIMAL HEALTH CORP (PAHC) reported total debt of $616.8 million, against $631.7 million a year earlier (-2.4%). Source: the 10-Q filed with the SEC on Nov 4, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PAHC&period_type=annual&limit=5"Information only, not investment advice.